News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
4D Molecular Therapeutics, Inc. - Common Stock
(NQ:
FDMT
)
10.14
+0.21 (+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 4D Molecular Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Jim Cramer: AppLovin Calls For Prudence, This Health Care Stock Is 'Pure Spec'
↗
September 03, 2025
Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent," he said.
Via
Benzinga
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
September 02, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Participate in Upcoming Investor Conferences
August 25, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces New Employment Inducement Grants
August 15, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
↗
August 12, 2025
Via
Benzinga
4dMT Revenue Jumps 200 Percent in Q2
↗
August 11, 2025
Via
The Motley Fool
Topics
Intellectual Property
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
August 11, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
August 06, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 04, 2025
Via
Benzinga
Unusual volume stocks in Monday's session
↗
August 04, 2025
Unusual volume stocks are being observed in Monday's session.
Via
Chartmill
Assessing 4D Molecular Therapeutics: Insights From 5 Financial Analysts
↗
August 01, 2025
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 01, 2025
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
August 01, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study
↗
August 01, 2025
4D Molecular's 4D-150 showed sustained vision and anatomical improvements with fewer injections in DME, supported by regulatory alignment.
Via
Benzinga
These stocks that are showing activity before the opening bell on Friday.
↗
August 01, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 01, 2025
Via
Benzinga
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
August 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 31, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
July 31, 2025
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
July 31, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists
July 24, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces New Employment Inducement Grants
July 11, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
↗
July 03, 2025
Via
Benzinga
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution
July 02, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Participate in Upcoming Investor Conferences
May 28, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces New Employment Inducement Grants
May 16, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
May 08, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT to Participate in Upcoming Investor Conferences
May 05, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
May 01, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
4DMT Announces New Employment Inducement Grants
April 11, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
